
CG Oncology, Inc. Common stock
USD54.42
-1.11 (-2.00%)
CEO
Arthur Kuan
IPO Date
2024-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.34
Prev. Close
$55.53
Day Low
$54.09
Day High
$56.98
52W Low
$23.65
52W High
$75.50
Market Cap
$4.80B
Volume
0.96M
| 11 May 2026 |
| RBC Capital |
| Outperform |
| Outperform |
| maintain |
| 11 May 2026 | Truist Securities | Buy | Buy | maintain |
| 11 May 2026 | Wedbush | Outperform | Outperform | maintain |
| 27 Apr 2026 | RBC Capital | Outperform | Outperform | maintain |
| 17 Apr 2026 | JP Morgan | Overweight | Overweight | maintain |
| 7 Apr 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 27 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |